Researchers are exploring genetic forms of population control called gene drives that spread traits faster that happens naturally. The goal is to curb mosquito-borne diseases like malaria.
Academic rigor, journalistic flair
Articles on Gene editing
Displaying 1 - 20 of 54 articles
CRISPR babies may be just the beginning. China has a different take than the West on ethics and how to get ahead in business and other endeavors.
Genome editing technology has, and will always have, limits. Limits that are related not to the technology itself but to the intrinsic complexity of the human genome.
Gene editing through CRISPR may have greater consequences than climate change or unleashing the energy of the atom.
In an era of big scientific collaborations, China's renegade actions have hurt its reputation. As international researchers back away, it may be the country's military that ultimately suffers.
Questions abound about whether the scientist who created the first gene edited human beings took shortcuts in the ethical oversight process. But pedantically focusing on protocol misses the point.
Chinese researcher, Jainkui He claims to have created the world's first genome-edited twins. Such action would pose unknown risks to the lives of these children and to humanity as a whole.
The announcement of the birth of babies with edited genes has been met by a deluge of scientific and ethical criticism. Public discussion focuses on risks and benefits – was breaking this taboo worth it?
A Chinese scientist has revealed he edited the DNA of twin girls born through in vitro fertilization. These girls are designed to be resistant to HIV. Is the edit a medical necessity or an enhancement?
We don't know anything about the health of the baby girls who are reported to have been born. But it's clear scientists around the world are shocked.
A Chinese scientist claims to have edited human DNA to make us more resistant to HIV. Here's why that's not good news.
Gene editing of wild plants can help us tap into new sources of food. But we need to make sure it's safe – and that demands some careful regulation.
Once genetic lesions for diseases such as cystic fibrosis and haemophilia were identified, the idea of replacing or correcting defective genes grew into what we now call "gene therapy".
Synthetic biology is highly promising – but if we don't get the regulation and engagement right, we risk alienating members of the public, and may even close doors for potentially fruitful research.
For several billion people mosquitoes are more than a nuisance -- they transmit deadly diseases. Now genetic modification may prove the most effective defense against the mosquito, preventing disease.
Basic research can be easy to mock as pointless and wasteful of resources. But it's very often the foundation for future innovation – even in ways the original scientists couldn't have imagined.
CRISPR has been hailed as the an editing tool that can delete inherited mutations and cure disease. But recent papers suggest that the technique may be too dangerous for use in human therapies.
Genetic modification rules now cover gene edited crops but exclude plants bred traditionally with the same properties.
A new study found the Cas9 gene editing scissors don't stop cutting after we tell them to.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
Top contributors
-
Deputy Vice-Chancellor Academic and Professor of Molecular Biology, UNSW
-
Research Assistant Professor in Biomedical Ethics, National University of Singapore
-
Visiting Professor in Biomedical Ethics, Murdoch Childrens Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Doctoral Student in Biochemistry, University of Washington
-
University Research Professor, Dalhousie University
-
Deputy Director - Centre for Stem Cell Systems and Head of Engagements, Ethics & Policy Program, Stem Cells Australia, University of Melbourne
-
Research Fellow in Biomedical Ethics, University of Melbourne
-
Professor of Bioethics & Medicine, Sydney Health Ethics, University of Sydney
-
Associate Professor, Cumming School of Medicine, University of Calgary
-
Professor of History and Associate Dean Research (Faculty of Arts), University of Adelaide
-
Research Professor of Epidemiology, Emory University
-
Postdoctoral research fellow, School of Mathematical Sciences, University of Adelaide
-
Professor, Australian National University
-
Senior Lecturer, School of BioSciences, University of Melbourne
